Annual EBITDA
$70.42 M
+$11.74 M+20.00%
31 December 2023
Summary:
Core Laboratories NV annual earnings before interest, taxes, depreciation & amortization is currently $70.42 million, with the most recent change of +$11.74 million (+20.00%) on 31 December 2023. During the last 3 years, it has risen by +$126.36 million (+225.90%). CLB annual EBITDA is now -81.13% below its all-time high of $373.23 million, reached on 31 December 2014.CLB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$23.48 M
+$3.70 M+18.71%
30 September 2024
Summary:
Core Laboratories NV quarterly earnings before interest, taxes, depreciation & amortization is currently $23.48 million, with the most recent change of +$3.70 million (+18.71%) on 30 September 2024. Over the past year, it has increased by +$4.88 million (+26.22%). CLB quarterly EBITDA is now -75.88% below its all-time high of $97.35 million, reached on 31 December 2014.CLB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$74.13 M
+$4.88 M+7.04%
30 September 2024
Summary:
Core Laboratories NV TTM earnings before interest, taxes, depreciation & amortization is currently $74.13 million, with the most recent change of +$4.88 million (+7.04%) on 30 September 2024. Over the past year, it has increased by +$2.47 million (+3.44%). CLB TTM EBITDA is now -80.14% below its all-time high of $373.23 million, reached on 31 December 2014.CLB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.0% | +26.2% | +3.4% |
| 3 y3 years | +225.9% | +110.8% | +1.0% |
| 5 y5 years | -50.3% | -36.4% | -36.3% |
CLB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +225.9% | at high | +463.6% | at high | +48.5% |
| 5 y | 5 years | -50.3% | +225.9% | -36.4% | +122.7% | -37.9% | +228.7% |
| alltime | all time | -81.1% | +225.9% | -75.9% | +122.7% | -80.1% | +228.7% |
Core Laboratories NV EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.48 M(+18.7%) | $74.13 M(+7.0%) |
| June 2024 | - | $19.78 M(+59.3%) | $69.25 M(-4.2%) |
| Mar 2024 | - | $12.41 M(-32.7%) | $72.31 M(+2.7%) |
| Dec 2023 | $70.42 M(+20.0%) | $18.45 M(-0.8%) | $70.42 M(-1.7%) |
| Sept 2023 | - | $18.60 M(-18.6%) | $71.66 M(-0.3%) |
| June 2023 | - | $22.84 M(+117.0%) | $71.88 M(+10.5%) |
| Mar 2023 | - | $10.53 M(-46.5%) | $65.04 M(+10.8%) |
| Dec 2022 | $58.69 M(-8.0%) | $19.69 M(+4.7%) | $58.69 M(+1.9%) |
| Sept 2022 | - | $18.82 M(+17.5%) | $57.59 M(+15.4%) |
| June 2022 | - | $16.01 M(+284.3%) | $49.91 M(-3.0%) |
| Mar 2022 | - | $4.17 M(-77.6%) | $51.45 M(-19.3%) |
| Dec 2021 | $63.78 M(-214.0%) | $18.60 M(+67.0%) | $63.78 M(-13.1%) |
| Sept 2021 | - | $11.14 M(-36.6%) | $73.42 M(-6.8%) |
| June 2021 | - | $17.55 M(+6.4%) | $78.78 M(+22.9%) |
| Mar 2021 | - | $16.49 M(-41.6%) | $64.09 M(-214.6%) |
| Dec 2020 | -$55.94 M(-146.9%) | $28.24 M(+71.2%) | -$55.94 M(-2.9%) |
| Sept 2020 | - | $16.50 M(+477.2%) | -$57.59 M(+54.9%) |
| June 2020 | - | $2.86 M(-102.8%) | -$37.18 M(+495.5%) |
| Mar 2020 | - | -$103.53 M(-489.4%) | -$6.24 M(-105.2%) |
| Dec 2019 | $119.29 M(-15.8%) | $26.59 M(-27.9%) | $119.29 M(+2.5%) |
| Sept 2019 | - | $36.90 M(+9.2%) | $116.40 M(-3.0%) |
| June 2019 | - | $33.79 M(+53.6%) | $120.05 M(-4.4%) |
| Mar 2019 | - | $22.00 M(-7.2%) | $125.58 M(-11.4%) |
| Dec 2018 | $141.71 M(+5.4%) | $23.70 M(-41.6%) | $141.71 M(-9.4%) |
| Sept 2018 | - | $40.56 M(+3.2%) | $156.45 M(+5.3%) |
| June 2018 | - | $39.32 M(+3.1%) | $148.56 M(+4.0%) |
| Mar 2018 | - | $38.13 M(-0.8%) | $142.78 M(+6.2%) |
| Dec 2017 | $134.49 M(+17.6%) | $38.44 M(+17.7%) | $134.49 M(+7.3%) |
| Sept 2017 | - | $32.66 M(-2.6%) | $125.39 M(+3.7%) |
| June 2017 | - | $33.54 M(+12.4%) | $120.94 M(+5.7%) |
| Mar 2017 | - | $29.84 M(+1.7%) | $114.38 M(+0.0%) |
| Dec 2016 | $114.32 M(-39.4%) | $29.35 M(+4.0%) | $114.32 M(-1.2%) |
| Sept 2016 | - | $28.21 M(+4.6%) | $115.67 M(-18.1%) |
| June 2016 | - | $26.98 M(-9.4%) | $141.19 M(-16.5%) |
| Mar 2016 | - | $29.79 M(-3.0%) | $169.03 M(-10.3%) |
| Dec 2015 | $188.53 M(-49.5%) | $30.69 M(-42.9%) | $188.53 M(-26.1%) |
| Sept 2015 | - | $53.73 M(-2.0%) | $255.18 M(-14.2%) |
| June 2015 | - | $54.82 M(+11.2%) | $297.42 M(-10.7%) |
| Mar 2015 | - | $49.28 M(-49.4%) | $333.05 M(-10.8%) |
| Dec 2014 | $373.23 M(+4.0%) | $97.35 M(+1.4%) | $373.23 M(+0.7%) |
| Sept 2014 | - | $95.97 M(+6.1%) | $370.52 M(+1.3%) |
| June 2014 | - | $90.45 M(+1.1%) | $365.91 M(+0.7%) |
| Mar 2014 | - | $89.46 M(-5.5%) | $363.29 M(+1.2%) |
| Dec 2013 | $358.89 M(+12.1%) | $94.65 M(+3.6%) | $358.89 M(+3.8%) |
| Sept 2013 | - | $91.35 M(+4.0%) | $345.61 M(+2.8%) |
| June 2013 | - | $87.83 M(+3.3%) | $336.10 M(+3.3%) |
| Mar 2013 | - | $85.06 M(+4.5%) | $325.47 M(+1.6%) |
| Dec 2012 | $320.20 M(+17.3%) | $81.37 M(-0.6%) | $320.20 M(+0.8%) |
| Sept 2012 | - | $81.84 M(+6.0%) | $317.51 M(+4.1%) |
| June 2012 | - | $77.20 M(-3.2%) | $304.94 M(+4.7%) |
| Mar 2012 | - | $79.79 M(+1.4%) | $291.13 M(+6.6%) |
| Dec 2011 | $273.05 M(+10.1%) | $78.67 M(+13.6%) | $273.05 M(+4.8%) |
| Sept 2011 | - | $69.27 M(+9.3%) | $260.46 M(+1.5%) |
| June 2011 | - | $63.40 M(+2.8%) | $256.55 M(+1.5%) |
| Mar 2011 | - | $61.70 M(-6.6%) | $252.63 M(+1.8%) |
| Dec 2010 | $248.10 M(+17.7%) | $66.09 M(+1.1%) | $248.10 M(+6.7%) |
| Sept 2010 | - | $65.36 M(+9.9%) | $232.61 M(+7.0%) |
| June 2010 | - | $59.49 M(+4.1%) | $217.48 M(+0.9%) |
| Mar 2010 | - | $57.17 M(+13.0%) | $215.58 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $210.74 M(-10.6%) | $50.60 M(+0.8%) | $210.80 M(-6.5%) |
| Sept 2009 | - | $50.22 M(-12.8%) | $225.45 M(-4.4%) |
| June 2009 | - | $57.59 M(+9.9%) | $235.86 M(-1.2%) |
| Mar 2009 | - | $52.38 M(-19.7%) | $238.64 M(+1.2%) |
| Dec 2008 | $235.68 M(+15.9%) | $65.25 M(+7.6%) | $235.86 M(+0.4%) |
| Sept 2008 | - | $60.63 M(+0.4%) | $234.85 M(+4.1%) |
| June 2008 | - | $60.37 M(+21.7%) | $225.57 M(+6.2%) |
| Mar 2008 | - | $49.61 M(-22.8%) | $212.37 M(+3.8%) |
| Dec 2007 | $203.32 M(+43.9%) | $64.24 M(+25.1%) | $204.68 M(+12.4%) |
| Sept 2007 | - | $51.35 M(+8.9%) | $182.08 M(+7.7%) |
| June 2007 | - | $47.16 M(+12.5%) | $169.06 M(+7.6%) |
| Mar 2007 | - | $41.92 M(+0.7%) | $157.17 M(+9.3%) |
| Dec 2006 | $141.25 M(+81.1%) | $41.64 M(+8.6%) | $143.79 M(+16.7%) |
| Sept 2006 | - | $38.34 M(+8.7%) | $123.25 M(+19.5%) |
| June 2006 | - | $35.27 M(+23.6%) | $103.17 M(+16.3%) |
| Mar 2006 | - | $28.54 M(+35.3%) | $88.73 M(+13.8%) |
| Dec 2005 | $77.99 M(+22.0%) | $21.09 M(+15.5%) | $77.99 M(+2.1%) |
| Sept 2005 | - | $18.26 M(-12.3%) | $76.36 M(+1.2%) |
| June 2005 | - | $20.83 M(+17.0%) | $75.45 M(+11.5%) |
| Mar 2005 | - | $17.81 M(-8.5%) | $67.67 M(+5.6%) |
| Dec 2004 | $63.91 M(+13.8%) | $19.46 M(+12.1%) | $64.11 M(+1.7%) |
| Sept 2004 | - | $17.36 M(+33.0%) | $63.05 M(+0.5%) |
| June 2004 | - | $13.05 M(-8.4%) | $62.72 M(+0.6%) |
| Mar 2004 | - | $14.24 M(-22.6%) | $62.32 M(+10.7%) |
| Dec 2003 | $56.16 M(+38.6%) | $18.40 M(+8.0%) | $56.31 M(+14.2%) |
| Sept 2003 | - | $17.03 M(+34.6%) | $49.30 M(+8.7%) |
| June 2003 | - | $12.65 M(+53.7%) | $45.34 M(+1.3%) |
| Mar 2003 | - | $8.23 M(-27.7%) | $44.76 M(-6.7%) |
| Dec 2002 | $40.52 M(-34.7%) | $11.39 M(-12.8%) | $47.99 M(+7.5%) |
| Sept 2002 | - | $13.07 M(+8.2%) | $44.63 M(-14.1%) |
| June 2002 | - | $12.07 M(+5.3%) | $51.95 M(-9.3%) |
| Mar 2002 | - | $11.46 M(+42.7%) | $57.30 M(-7.8%) |
| Dec 2001 | $62.09 M(+15.5%) | $8.03 M(-60.6%) | $62.13 M(-12.8%) |
| Sept 2001 | - | $20.39 M(+17.1%) | $71.21 M(+8.7%) |
| June 2001 | - | $17.42 M(+7.0%) | $65.48 M(+8.8%) |
| Mar 2001 | - | $16.29 M(-4.8%) | $60.16 M(+11.5%) |
| Dec 2000 | $53.75 M(+37.3%) | $17.11 M(+16.6%) | $53.95 M(+21.5%) |
| Sept 2000 | - | $14.67 M(+21.2%) | $44.41 M(-1.6%) |
| June 2000 | - | $12.10 M(+20.1%) | $45.11 M(+5.8%) |
| Mar 2000 | - | $10.08 M(+33.3%) | $42.64 M(+9.4%) |
| Dec 1999 | $39.16 M(-31.3%) | $7.56 M(-50.8%) | $38.99 M(-12.7%) |
| Sept 1999 | - | $15.37 M(+59.6%) | $44.64 M(-9.4%) |
| June 1999 | - | $9.63 M(+49.8%) | $49.27 M(-8.0%) |
| Mar 1999 | - | $6.43 M(-51.3%) | $53.54 M(-6.4%) |
| Dec 1998 | $57.01 M(+36.7%) | $13.21 M(-33.9%) | $57.21 M(-5.4%) |
| Sept 1998 | - | $20.00 M(+43.9%) | $60.50 M(+16.1%) |
| June 1998 | - | $13.90 M(+37.6%) | $52.10 M(+9.9%) |
| Mar 1998 | - | $10.10 M(-38.8%) | $47.40 M(+13.1%) |
| Dec 1997 | $41.70 M(+143.9%) | $16.50 M(+42.2%) | $41.90 M(+39.7%) |
| Sept 1997 | - | $11.60 M(+26.1%) | $30.00 M(+29.3%) |
| June 1997 | - | $9.20 M(+100.0%) | $23.20 M(+28.2%) |
| Mar 1997 | - | $4.60 M(0.0%) | $18.10 M(+4.0%) |
| Dec 1996 | $17.10 M(+29.5%) | $4.60 M(-4.2%) | $17.40 M(+6.7%) |
| Sept 1996 | - | $4.80 M(+17.1%) | $16.30 M(+9.4%) |
| June 1996 | - | $4.10 M(+5.1%) | $14.90 M(-49.3%) |
| Mar 1996 | - | $3.90 M(+11.4%) | $29.40 M(-32.1%) |
| Dec 1995 | $13.20 M | $3.50 M(+2.9%) | $43.30 M(+8.8%) |
| Sept 1995 | - | $3.40 M(-81.7%) | $39.80 M(+9.3%) |
| June 1995 | - | $18.60 M(+4.5%) | $36.40 M(+104.5%) |
| Mar 1995 | - | $17.80 M | $17.80 M |
FAQ
- What is Core Laboratories NV annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Core Laboratories NV?
- What is Core Laboratories NV annual EBITDA year-on-year change?
- What is Core Laboratories NV quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Core Laboratories NV?
- What is Core Laboratories NV quarterly EBITDA year-on-year change?
- What is Core Laboratories NV TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Core Laboratories NV?
- What is Core Laboratories NV TTM EBITDA year-on-year change?
What is Core Laboratories NV annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CLB is $70.42 M
What is the all time high annual EBITDA for Core Laboratories NV?
Core Laboratories NV all-time high annual earnings before interest, taxes, depreciation & amortization is $373.23 M
What is Core Laboratories NV annual EBITDA year-on-year change?
Over the past year, CLB annual earnings before interest, taxes, depreciation & amortization has changed by +$11.74 M (+20.00%)
What is Core Laboratories NV quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CLB is $23.48 M
What is the all time high quarterly EBITDA for Core Laboratories NV?
Core Laboratories NV all-time high quarterly earnings before interest, taxes, depreciation & amortization is $97.35 M
What is Core Laboratories NV quarterly EBITDA year-on-year change?
Over the past year, CLB quarterly earnings before interest, taxes, depreciation & amortization has changed by +$4.88 M (+26.22%)
What is Core Laboratories NV TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CLB is $74.13 M
What is the all time high TTM EBITDA for Core Laboratories NV?
Core Laboratories NV all-time high TTM earnings before interest, taxes, depreciation & amortization is $373.23 M
What is Core Laboratories NV TTM EBITDA year-on-year change?
Over the past year, CLB TTM earnings before interest, taxes, depreciation & amortization has changed by +$2.47 M (+3.44%)